Microangiopathic Hemolytic Anemia
Educational overview only. This page summarizes publicly available health information for general understanding and awareness. It does not provide medical advice, diagnosis, or treatment. For personalized guidance or care decisions, consult a qualified healthcare professional.
📋Overview
Microangiopathic hemolytic anemia (MAHA) is a descriptive term for a type of anemia caused by the destruction of red blood cells as they pass through small damaged blood vessels. It is not a standalone disease but a pathological process seen in various conditions such as thrombotic microangiopathies (e.g., thrombotic thrombocytopenic purpura, hemolytic uremic syndrome), malignant hypertension, and disseminated intravascular coagulation. The modern approach focuses on identifying and treating the underlying cause.
Sections:
Additional Resources
Medical codes (for reference)
UMLS CUI: C0221021ICD-10-CM
D59.4
MeSH
D000743
SNOMED CT (US)
51071000
Codes are provided for reference and interoperability. They are not a diagnosis.
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.